9-135524925-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002297.4(LCN1):āc.499C>Gā(p.Gln167Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,605,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002297.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCN1 | NM_002297.4 | c.499C>G | p.Gln167Glu | missense_variant | 5/7 | ENST00000371781.4 | NP_002288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCN1 | ENST00000371781.4 | c.499C>G | p.Gln167Glu | missense_variant | 5/7 | 1 | NM_002297.4 | ENSP00000360846 | P1 | |
LCN1 | ENST00000263598.6 | c.499C>G | p.Gln167Glu | missense_variant | 5/7 | 1 | ENSP00000263598 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000299 AC: 7AN: 234472Hom.: 0 AF XY: 0.0000158 AC XY: 2AN XY: 126862
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1453242Hom.: 0 Cov.: 31 AF XY: 0.00000831 AC XY: 6AN XY: 722394
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2021 | The c.499C>G (p.Q167E) alteration is located in exon 5 (coding exon 5) of the LCN1 gene. This alteration results from a C to G substitution at nucleotide position 499, causing the glutamine (Q) at amino acid position 167 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at